AbbVie (ABBV) is a biotechnology company in the Health Care sector. Listed on the NASDAQ, AbbVie is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $224.95.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $224.95 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 19.83% |
| Risk / Std Dev (Annualized) | 22.90% |
| Sharpe Ratio (rf=4.5%) | 0.67 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Biotechnology
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 19.83% with an annualized volatility of 22.90%. The Sharpe ratio of 0.67 (assuming 4.5% risk-free rate) indicates moderate risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 397.44B |
| Enterprise Value | 461.01B |
| Trailing P/E | 109.73 |
| Forward P/E | 13.84 |
| Price to Book | -59.72 |
| Price to Sales | 6.33 |
| EV/Revenue | 7.34 |
| EV/EBITDA | 15.41 |
| Profitability | | | Profit Margin | 5.79% | | Operating Margin | 32.16% | | ROA | 10.03% |
| Growth | | | Revenue Growth | 12.4% | | Earnings Growth | -46.2% |
| Dividend | | | Dividend Yield | 308.0% | | Payout Ratio | 325.98% | | 5Y Avg Yield | 360.0% |
| Financial Health | | | Total Revenue | 62.82B | | Total Debt | 72.91B | | Total Cash | 9.39B | | Free Cash Flow | 20.81B | | Operating Cash Flow | 21.22B |
| Price & Technical | | | 52W High | $244.81$ | | 52W Low | $181.73$ | | 50-Day Avg | $210.17$ | | 200-Day Avg | $220.1$ | | Beta | 0.31 | | Shares Outstanding | 1.77B | | Float Shares | 1.76B | | Insider Holdings | 0.11% | | Institutional Holdings | 76.89% | | Short Ratio | 3.88 | | Short % of Float | 1.46% |
| Analyst Targets | | | Target High | $328.0$ | | Target Low | $184.0$ | | Target Mean | $253.55$ | | Target Median | $258.0$ | | # of Analysts | 29 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.